Wang Q, Lasset C, Desseigne F, Saurin J C, Maugard C, Navarro C, Ruano E, Descos L, Trillet-Lenoir V, Bosset J F, Puisieux A
Département d'Oncologie Fondamentale et Appliquée, INSERM Unité 453, Centre Léon Bérard, Lyon, France.
Hum Genet. 1999 Jul-Aug;105(1-2):79-85. doi: 10.1007/s004399900064.
Hereditary nonpolyposis colorectal cancer (HNPCC) is a syndrome characterized by familial predisposition to colorectal carcinoma and extracolonic cancers of the gastrointestinal, urological, and female reproductive tracts. This dominant disorder is caused by germline defects in one of at least five DNA mismatch repair (MMR) genes: hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 (GTBP). Germline mutations of hMSH2 and hMLH1 are also frequently identified in families not fulfilling all the Amsterdam criteria, thereby demonstrating that the involvement of these genes is not confined to typical HNPCC. To evaluate the respective involvement of the various MMR genes in typical and incomplete HNPCC syndromes, we have performed an analysis of the hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in a large series of French kindreds (n=75) with colorectal tumors and/or aggregation of extracolonic cancers belonging to the HNPCC spectrum. Mutational analysis has been performed in all families, without preselection for the tumor phenotype. We have detected 26 pathogenic germline mutations of the hMLH1 and hMSH2 genes and several novel variants of the hPMS1, hPMS2, and hMSH6 genes. Our data confirm that, regardless of the type of families and the tumor phenotype, hPMS1, hPMS2, and hMSH6 germline mutations are rare in familial aggregation of colorectal cancers. Furthermore, they suggest that the presence of multiple primary malignancies in a single individual and the observation of extracolonic tumors in relatives of a colorectal cancer patient should be included among the guidelines for referring patients for genetic testing.
遗传性非息肉病性结直肠癌(HNPCC)是一种综合征,其特征为家族性易患结直肠癌以及胃肠道、泌尿系统和女性生殖道的结外癌症。这种显性疾病是由至少五个DNA错配修复(MMR)基因之一的种系缺陷引起的:hMLH1、hMSH2、hPMS1、hPMS2和hMSH6(GTBP)。在不符合所有阿姆斯特丹标准的家族中也经常发现hMSH2和hMLH1的种系突变,从而表明这些基因的参与并不局限于典型的HNPCC。为了评估各种MMR基因在典型和不完全HNPCC综合征中的各自参与情况,我们对一大系列法国家系(n = 75)中的hMLH1、hMSH2、hPMS1、hPMS2和hMSH6基因进行了分析,这些家系患有结直肠肿瘤和/或属于HNPCC谱系的结外癌症聚集。对所有家族都进行了突变分析,没有对肿瘤表型进行预选。我们检测到hMLH1和hMSH2基因的26个致病性种系突变以及hPMS1、hPMS2和hMSH6基因的几个新变体。我们的数据证实,无论家族类型和肿瘤表型如何,hPMS1、hPMS2和hMSH6种系突变在结直肠癌家族聚集中都很罕见。此外,数据表明,个体中存在多个原发性恶性肿瘤以及在结直肠癌患者亲属中观察到结外肿瘤应纳入推荐患者进行基因检测的指南中。